Market Alert: ASX200 at Critical Support – Reversal or Further Fall?

Vection Technologies Expands Recurring AI Revenue with Strategic Wins

Apr 08, 2025

Vection Technologies Ltd (ASX: VR1), a leader in integrated extended reality (XR) and artificial intelligence (AI), has secured an additional AU$0.6 million in annual recurring revenue through its generative AI subsidiary, The Digital Box (TDB). This brings TDB’s total new AI-driven contracts to AU$1.3 million since its March 2025 acquisition. Fourteen new clients, including notable names like NexyLab, Sella GenAI, and Italy’s Parliament, have adopted TDB’s AI-powered software, kiosk, and professional services. These deals demonstrate Vection’s growing market traction and its ability to deliver scalable, subscription-based digital transformation solutions. Approximately AU$0.36 million of the new revenue will be recognised in FY25, with the remainder in early FY26. Vection's strategy of merging AI and XR technologies continues to gain momentum, reinforcing its position as a key player in enterprise digital innovation across global markets. The announcement meets the company’s materiality threshold and reflects strong investor confidence.

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com